Intra-Cellular Therapies Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2020
Market Capitalization	36,075	29,712	30,042	25,252	-	-	Upgrade
Market Cap Growth	24.12%	-1.10%	18.97%	-	-	-	Upgrade
Enterprise Value	34,220	28,155	29,131	24,450	-	-	Upgrade
Last Close Price	2385.00	1965.00	1998.53	1797.08	-	-	Upgrade
PE Ratio	40.03	36.77	49.09	56.24	-	-	Upgrade
Forward PE	-	61.52	61.52	49.36	-	-	Upgrade
PS Ratio	13.11	11.56	14.52	15.75	-	-	Upgrade
PB Ratio	14.49	12.33	17.78	22.85	-	-	Upgrade
P/TBV Ratio	15.40	13.06	18.97	25.15	-	-	Upgrade
P/FCF Ratio	-	35.41	68.28	47.92	-	-	Upgrade
P/OCF Ratio	-	34.71	47.99	46.50	-	-	Upgrade
EV/Sales Ratio	12.44	10.95	14.08	15.25	-	-	Upgrade
EV/EBITDA Ratio	-	23.15	30.09	33.72	-	-	Upgrade
EV/EBIT Ratio	26.76	24.79	32.05	35.28	-	-	Upgrade
EV/FCF Ratio	-	33.56	66.21	46.39	-	-	Upgrade
Debt / Equity Ratio	-	-	0.05	0.09	0.36	1.37	Upgrade
Debt / EBITDA Ratio	-	-	0.09	0.13	-	-	Upgrade
Debt / FCF Ratio	-	-	0.21	0.18	-	-	Upgrade
Asset Turnover	1.06	0.94	1.03	1.18	1.43	-	Upgrade
Quick Ratio	6.16	4.42	3.11	3.08	2.25	1.81	Upgrade
Current Ratio	6.33	4.52	3.16	3.11	2.28	1.85	Upgrade
Return on Equity (ROE)	43.36%	39.42%	43.79%	55.85%	102.10%	-	Upgrade
Return on Assets (ROA)	30.84%	26.05%	28.20%	31.96%	30.07%	-	Upgrade
Return on Capital (ROIC)	37.34%	33.89%	38.12%	46.00%	46.96%	-	Upgrade
Return on Capital Employed (ROCE)	49.30%	45.20%	50.70%	57.90%	59.10%	58.70%	Upgrade
Earnings Yield	2.52%	2.72%	2.04%	1.78%	-	-	Upgrade
FCF Yield	-	2.82%	1.47%	2.09%	-	-	Upgrade
Payout Ratio	-	18.44%	16.99%	-	-	-	Upgrade
Buyback Yield / Dilution	-60.41%	-100.31%	-10.28%	-9.38%	-	-	Upgrade

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.